BIO-key Q2 revenue up 49% to $1.7M; launches CyberDefense Initiative for defense contracts

BIO KEY INTERNATIONAL INC

Q2 revenue $1.70M vs $1.14M YoY; net loss improved to ($1.17M) or ($0.20)/share from ($1.67M) or ($1.00)/share.
Gross margin 73% vs 77% YoY due to higher hardware mix; hardware sales surged to $569K from $83K.
BIO-key launches CyberDefense Initiative targeting military/defense IAM; cites $350B EU defense spending.
Notes payable reduced by $0.4M in Q2, balance $0.3M; cash $2.3M at June 30, 2025.
Platform modernization for PortalGuard IDaaS targeted for Q4'25 release.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.